Home › Acute Biphenotypic Leukemia › Oklahoma › Tulsa
Acute Biphenotypic Leukemia clinical trials in Tulsa, OK
3 studies for Acute Biphenotypic Leukemia are looking for participants at sites in and around Tulsa (within about 30 miles). Open a study to see who can join and how to contact the study team.
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RecruitingPhase 3
- Saint Francis Children's Hospital, Tulsa
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
RecruitingPhase 2
- Saint Francis Children's Hospital, Tulsa
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
RecruitingPhase 4
- Saint Francis Children's Hospital, Tulsa
Acute Biphenotypic Leukemia trials in other cities
- Seattle, WA15 studies
- Houston, TX11 studies
- New York City, NY10 studies
- Atlanta, GA9 studies
- Durham, NC8 studies
- Memphis, TN7 studies
- Chicago, IL7 studies
- Charlotte, NC6 studies
- Philadelphia, PA6 studies
- Aurora, CO6 studies
- Dallas, TX6 studies
- Baldwin Park, CA6 studies
Other studies in Tulsa
- Heart Failure9 studies
- Overweight6 studies
- Melanoma5 studies
- Ischemic Stroke5 studies
- Obesity5 studies
- Aortic Valve Stenosis4 studies
- Depression4 studies
- Endometrial Cancer4 studies
- Cancer (all types)4 studies
- Breast Cancer4 studies
- Parkinson's Disease4 studies
- Ovarian Cancer4 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.